Treatment of Railway medical beneficiaries at Tata Memorial Centre Mumbai
GOVERNMENT OF INDIA
MINISTRY OF RAILWAYS
RAILWAY BOARD
No. 2014/H/15/I/AIRF
New Delhi,
dated 27.04.2018
General Manager(s)
All Indian Railways,
(facluding PUs and RDSO)
Sub: Treatment of Railway medical beneficiaries at Tata Memorial Centre Mumbai – Reg.
M/s Tata Memorial Centre Mumbai has been accorded permanent recognition for cancer treatment of Railway medical beneficiaries. Such beneficiaries are referred to Tata Memorial Centre through Central/Western Railways. In many cases, it is noted that when cancer patients from zones other than Central and Western Railways are referred to Tata Memorial Centre Mumbai, they have to go back to parent zones for getting approval of expenses if the amount of advance to be sanctioned for treatment exceeds certain limit. Such situations put unnecessary hardship to Railway medical beneficiaries who have to run from Mumbai to their parent zones located at far-off places for getting necessary approvals. In view of this, the issue of providing a permanent relief in such situations has been under consideration of Railway Board for sometime.
After careful consideration in the matter, it has now been decided that the proposals for sanction of advance in favour of Tata Memorial Centre Mumbai in cases of Railway medical beneficiaries from all zones who have initially been referred to TMH/Mumbai by Central/Western Railway and have been recommended Bone Marrow Transplant (MBT) by TMH/Mumbai, will be processed and advance sanctioned with the approval of Competent Authorities of Central/Western Railways through whom the patient has been referred to the hospital. After sanction, Central/Western Railway will raise debit to the concerned zone which that zone would be bound to accept. The sanction of advance amount will be limited to the financial limit contained in PGI/Chandigarh letter dated 28.10.2016 (copy enclosed) or subsequent instruction on the subject of BMT issued by CGHS. Also, before sanction of medical advance, an undertaking may be obtained from railway medical beneficiary to the effect that charges incurred on treatment beyond the prescribed financial limit for BMT procedure will be borne by him/her and no reimbursement claim to the effect will be preferred.
This issues with the approval of Finance Directorate in the Ministry of Railways.
S/d,
(R.S.Shukla)
Joint Director/Health
Railway Board